Biotech Industry Intelligence
Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win
Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win
Biotech Industry Intelligence
Wave crashes on obesity disappointment
Wave crashes on obesity disappointment
There’s a reason lots of companies are working on GLP-1-based drugs for obesity: The other stuff tends not to work. The latest biotech to learn this the hard way is Wave Life Sciences, which Read More
Biotech Industry Intelligence
Maze Loses Nearly a Third of Market Share on Mixed Midstage Kidney Drug Data
Maze Loses Nearly a Third of Market Share on Mixed Midstage Kidney Drug Data
Besting Vertex Pharmaceuticals’ kidney disease asset wasn’t enough to impress Wall Street, which appears to be “getting hung up” with the broad population data in Maze Therapeutics’ trial, according to Mizuho. Read More
Biotech Industry Intelligence
Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Boehringer Ingelheim said it plans to keep up high levels of R&D spending, and could look at China-based companies for dealmaking, as key planks of its strategic approach this year, board chairman Shashank Deshpande said … Read More
Widespread atropine use fails to sway FDA advisors on Sydnexis data
At least 11 PDUFAs on FDA’s November docket
FDA Grants Accelerated Approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for Recurrent Respiratory Papillomatosis
Auchincloss bill seeks to improve ‘operating system for science’
Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic
-
Uncategorized7 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Endpoints News8 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized6 months agoOptical Pooled CRISPR Screen Reveals Regulators of NF-κB Dynamics in Human Cells
-
Uncategorized6 months ago
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
-
Uncategorized5 months ago
Hybrid solid−liquid optics enable scalable, high-resolution light-sheet microscopy across diverse immersion media
-
Fierce Biotech7 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Nature Biotechnology8 months ago
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
-
BioPharma Dive – AI / Data7 months agoAstraZeneca lung drug gets ‘surprise’ win in COPD trials
Scan to Read